Infection Prevention Devices Market by Product and End User - Global Industry Analysis & Forecast to 2027

Published On : July 2019 Pages : 158 Category: Medical Devices Report Code : HC074494

Infection Prevention Devices Market by Product (Medical Waste Disposable Devices, Infection Prevention Supplies and Infection Prevention Equipment) and End User (Lifescience Industries, Hospitals, Clinical Laboratories and Others)- Global Industry Analysis & Forecast to 2027

Industry Outlook and Trend Analysis

Human services focuses are progressively perceiving the requirement for compelling disease control and anticipation. Some human services focuses taking measures for disease control by teaming up with infection prevention devices providers. Emerging nations advancing the idea of disease control and counteractive action by directing projects and disease control workshops that are required to give income chances to infection prevention devices suppliers.

Drivers and Restraints

The event and bothersome complexities from HAIs have been well-perceived throughout the previous a very long while. The event of HAIs keeps on ascending at a disturbing rate. HAIs initially allude to those diseases related with affirmation in an intense consideration emergency clinic; in any case, by and by, the term applies to contaminations obtained in the continuum of settings where people get healthcare. Technological progressions in the field of life sciences and biotechnology have achieved noteworthy changes in social insurance diagnostics, sedate disclosure, customized prescriptions, criminological sciences, and clinical research and improvement. This is a central point driving the worldwide infection prevention devices market.

Regional Insights

North America overwhelms the worldwide infection prevention devices market, trailed by Europe. Ascend in the geriatric populace and maturing people born after WW2 are main considerations for the predominant offer held by the U.S. in the infection prevention devices market in North America.

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Italy
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • India
    • Southeast Asia
    • Rest of Asia-Pacific
  • SouthAmerica
    • Brazil
    • Argentina
    • Columbia
    • Rest of South America
  • Middle East and Africa
    • Saudi Arabia
    • UAE
    • Egypt
    • Nigeria
    • South Africa
    • Rest of MEA

Competitive Analysis                         

The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.

  • PAUL HARTMANN AG
  • Cardinal Health
  • 3M Healthcare
  • B. Braun Melsungen AG
  • Johnson & Johnson
  • Mölnlycke Health Care AB
  • Ethicon, Inc.
  • Coloplast Group
  • C. R. Bard, Inc.
  • Medline Industries, Inc.

Some of the key questions answered by the report are:

  • What was the market size in 2017 and forecast from 2017 to 2027?
  • What will be the industry market growth from 2017 to 2027?
  • What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
  • What are the major segments leading the market growth and why?
  • Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?

Market Classification

·         Infection Prevention Devices Market, By Product, Estimates and Forecast, 2017-2027 ($Million)

o    Medical Waste Disposable Devices

o    Infection Prevention Supplies

o    Infection Prevention Equipment

·         Infection Prevention Devices Market, By End User, Estimates and Forecast, 2017-2027 ($Million)

o    Lifescience Industries

o    Hospitals

o    Clinical Laboratories

o    Others

·         Infection Prevention Devices Market, By Key Players

o    PAUL HARTMANN AG

o    Cardinal Health

o    3M Healthcare

o    B. Braun Melsungen AG

o    Johnson & Johnson

o    Mölnlycke Health Care AB

o    Ethicon, Inc.

o    Coloplast Group

o    C. R. Bard, Inc.

o    Medline Industries, Inc.

·         Infection Prevention Devices Market, By Region, Estimates and Forecast, 2017-2027 ($Million)

o    North America

§  North America Infection Prevention Devices Market, By Country

o    U.S. Infection Prevention Devices Market

o    Canada Infection Prevention Devices Market

o    Mexico Infection Prevention Devices Market

o    Europe

§  Europe Infection Prevention Devices Market, By Country

o    Germany Infection Prevention Devices Market

o    UK Infection Prevention Devices Market

o    France Infection Prevention Devices Market

o    Russia Infection Prevention Devices Market

o    Italy Infection Prevention Devices Market

o    Rest of Europe Infection Prevention Devices Market

o    Asia-Pacific

§  Asia-Pacific Infection Prevention Devices Market, By Country

o    China Infection Prevention Devices Market

o    Japan Infection Prevention Devices Market

o    South Korea Infection Prevention Devices Market

o    India Infection Prevention Devices Market

o    Southeast Asia Infection Prevention Devices Market

o    Rest of Asia-Pacific Infection Prevention Devices Market

o    South America

§  South America Infection Prevention Devices Market

o    Brazil Infection Prevention Devices Market

o    Argentina Infection Prevention Devices Market

o    Columbia Infection Prevention Devices Market

o    Rest of South America Infection Prevention Devices Market

o    Middle East and Africa

§  Middle East and Africa Infection Prevention Devices Market

o    Saudi Arabia Infection Prevention Devices Market

o    UAE Infection Prevention Devices Market

o    Egypt Infection Prevention Devices Market

o    Nigeria Infection Prevention Devices Market

o    South Africa Infection Prevention Devices Market

o    Rest of MEA Infection Prevention Devices Market

Table of Contents:

1.       Introduction

1.1.     Report Description

2.       Executive Summary

2.1.     Key Highlights

3.       Market Overview

3.1.     Introduction

3.1.1.  Market Definition

3.1.2.  Market Segmentation

3.2.     Market Dynamics

3.2.1.  Drivers

3.2.2.  Restraints

3.2.3.  Opportunities

4.       Market Analysis by Regions

4.1.     North America (United States, Canada and Mexico)

4.1.1.  United States Market Status and Outlook (2017-2027)

4.1.2.  Canada Market Status and Outlook (2017-2027)

4.1.3.  Mexico Market Status and Outlook (2017-2027)

4.2.     Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

4.2.1.  Germany Market Status and Outlook (2017-2027)

4.2.2.  France Market Status and Outlook (2017-2027)

4.2.3.  UK Market Status and Outlook (2017-2027)

4.2.4.  Russia Market Status and Outlook (2017-2027)

4.2.5.  Italy Market Status and Outlook (2017-2027)

4.2.6.  Rest of Europe Market Status and Outlook (2017-2027)

4.3.     Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)

4.3.1.  China Market Status and Outlook (2017-2027)

4.3.2.  Japan Market Status and Outlook (2017-2027)

4.3.3.  Korea Market Status and Outlook (2017-2027)

4.3.4.  India Market Status and Outlook (2017-2027)

4.3.5.  Southeast Asia Market Status and Outlook (2017-2027)

4.3.6.  Rest of Asia-Pacific Market Status and Outlook (2017-2027)

4.4.     South America (Brazil, Argentina, Columbia and Rest of South America)

4.4.1.  Brazil Market Status and Outlook (2017-2027)

4.4.2.  Argentina Market Status and Outlook (2017-2027)

4.4.3.  Columbia Market Status and Outlook (2017-2027)

4.4.4.  Rest of South America Market Status and Outlook (2017-2027)

4.5.     Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)

4.5.1.  Saudi Arabia Market Status and Outlook (2017-2027)

4.5.2.  United Arab Emirates Market Status and Outlook (2017-2027)

4.5.3.  Egypt Market Status and Outlook (2017-2027)

4.5.4.  Nigeria Market Status and Outlook (2017-2027)

4.5.5.  South Africa Market Status and Outlook (2017-2027)

4.5.6.  Turkey Market Status and Outlook (2017-2027)

4.5.7.  Rest of Middle East and Africa Market Status and Outlook (2017-2027)

5.       Infection Prevention Devices Market, By Product

5.1.     Introduction

5.2.     Global Infection Prevention Devices Revenue and Market Share by Product (2017-2027)

5.2.1.  Global Infection Prevention Devices Revenue and Revenue Share by Product (2017-2027)

5.3.     Medical Waste Disposable Devices

5.3.1.  Global Medical Waste Disposable Devices Revenue and Growth Rate (2017-2027)

5.4.     Infection Prevention Supplies

5.4.1.  Global Infection Prevention Supplies Revenue and Growth Rate (2017-2027)

5.5.     Infection Prevention Equipment

5.5.1.  Global Infection Prevention Equipment Revenue and Growth Rate (2017-2027)

6.       Infection Prevention Devices Market, By End User

6.1.     Introduction

6.2.     Global Infection Prevention Devices Revenue and Market Share by End User (2017-2027)

6.2.1.  Global Infection Prevention Devices Revenue and Revenue Share by End User (2017-2027)

6.3.     Lifescience Industries

6.3.1.  Global Lifescience Industries Revenue and Growth Rate (2017-2027)

6.4.     Hospitals

6.4.1.  Global Hospitals Revenue and Growth Rate (2017-2027)

6.5.     Clinical Laboratories

6.5.1.  Global Clinical Laboratories Revenue and Growth Rate (2017-2027)

6.6.     Others

6.6.1.  Global Others Revenue and Growth Rate (2017-2027)

7.       Infection Prevention Devices Market, By Region

7.1.     Introduction

7.2.     Global Infection Prevention Devices Revenue and Market Share by Regions

7.2.1.  Global Infection Prevention Devices Revenue by Regions (2017-2027)

7.3.     North America Infection Prevention Devices by Countries

7.3.1.  North America Infection Prevention Devices Revenue and Growth Rate (2017-2027)

7.3.2.  North America Infection Prevention Devices Revenue (Million USD) by Countries (2017-2027)

7.3.3.  United States

7.3.3.1.  United States Infection Prevention Devices Revenue (Millions USD) and Growth Rate (2017-2027)

7.3.4.  Canada

7.3.4.1.  Canada Infection Prevention Devices Revenue (Millions USD) and Growth Rate (2017-2027)

7.3.5.  Mexico

7.3.5.1.  Mexico Infection Prevention Devices Revenue (Millions USD) and Growth Rate (2017-2027)

7.4.     Europe Infection Prevention Devices by Countries

7.4.1.  Europe Infection Prevention Devices Revenue and Growth Rate (2017-2027)

7.4.2.  Europe Infection Prevention Devices Revenue (Million USD) by Countries (2017-2027)

7.4.3.  Germany

7.4.3.1.  Germany Infection Prevention Devices Revenue (Millions USD) and Growth Rate (2017-2027)

7.4.4.  France

7.4.4.1.  France Infection Prevention Devices Revenue (Millions USD) and Growth Rate (2017-2027)

7.4.5.  UK

7.4.5.1.  UK Infection Prevention Devices Revenue (Millions USD) and Growth Rate (2017-2027)

7.4.6.  Russia

7.4.6.1.  Russia Infection Prevention Devices Revenue (Millions USD) and Growth Rate (2017-2027)

7.4.7.  Italy

7.4.7.1.  Italy Infection Prevention Devices Revenue (Millions USD) and Growth Rate (2017-2027)

7.4.8.  Rest of Europe

7.4.8.1.  Rest of Europe Infection Prevention Devices Revenue (Millions USD) and Growth Rate (2017-2027)

7.5.     Asia-Pacific Infection Prevention Devices by Countries

7.5.1.  Asia-Pacific Infection Prevention Devices Revenue and Growth Rate (2017-2027)

7.5.2.  Asia-Pacific Infection Prevention Devices Revenue (Million USD) by Countries (2017-2027)

7.5.3.  China

7.5.3.1.  China Infection Prevention Devices Revenue (Millions USD) and Growth Rate (2017-2027)

7.5.4.  Japan

7.5.4.1.  Japan Infection Prevention Devices Revenue (Millions USD) and Growth Rate (2017-2027)

7.5.5.  Korea

7.5.5.1.  Korea Infection Prevention Devices Revenue (Millions USD) and Growth Rate (2017-2027)

7.5.6.  India

7.5.6.1.  India Infection Prevention Devices Revenue (Millions USD) and Growth Rate (2017-2027)

7.5.7.  Southeast Asia

7.5.7.1.  Southeast Asia Infection Prevention Devices Revenue (Millions USD) and Growth Rate (2017-2027)

7.5.8.  Rest of Asia-Pacific

7.5.8.1.  Rest of Asia-Pacific Infection Prevention Devices Revenue (Millions USD) and Growth Rate (2017-2027)

7.6.     South America Infection Prevention Devices by Countries

7.6.1.  South America Infection Prevention Devices Revenue and Growth Rate (2017-2027)

7.6.2.  South America Infection Prevention Devices Revenue (Million USD) by Countries (2017-2027)

7.6.3.  Brazil

7.6.3.1.  Brazil Infection Prevention Devices Revenue (Millions USD) and Growth Rate (2017-2027)

7.6.4.  Argentina

7.6.4.1.  Argentina Infection Prevention Devices Revenue (Millions USD) and Growth Rate (2017-2027)

7.6.5.  Columbia

7.6.5.1.  Columbia Infection Prevention Devices Revenue (Millions USD) and Growth Rate (2017-2027)

7.6.6.  Rest of South America

7.6.6.1.  Rest of South America Infection Prevention Devices Revenue (Millions USD) and Growth Rate (2017-2027)

7.7.     Middle East and Africa Infection Prevention Devices by Countries

7.7.1.  Middle East and Africa Infection Prevention Devices Revenue and Growth Rate (2017-2027)

7.7.2.  Middle East and Africa Infection Prevention Devices Revenue (Million USD) by Countries (2017-2027)

7.7.3.  Saudi Arabia

7.7.3.1.  Saudi Arabia Infection Prevention Devices Revenue (Millions USD) and Growth Rate (2017-2027)

7.7.4.  United Arab Emirates

7.7.4.1.  United Arab Emirates Infection Prevention Devices Revenue (Millions USD) and Growth Rate (2017-2027)

7.7.5.  Egypt

7.7.5.1.  Egypt Infection Prevention Devices Revenue (Millions USD) and Growth Rate (2017-2027)

7.7.6.  Nigeria

7.7.6.1.  Nigeria Infection Prevention Devices Revenue (Millions USD) and Growth Rate (2017-2027)

7.7.7.  South Africa

7.7.7.1.  South Africa Infection Prevention Devices Revenue (Millions USD) and Growth Rate (2017-2027)

7.7.8.  Turkey

7.7.8.1.  Turkey Infection Prevention Devices Revenue (Millions USD) and Growth Rate (2017-2027)

7.7.9.  Rest of Middle East and Africa

7.7.9.1.  Rest of Middle East and Africa Infection Prevention Devices Revenue (Millions USD) and Growth Rate (2017-2027)

8.       Company Profiles

8.1.     PAUL HARTMANN AG

8.1.1.  Business Overview

8.1.2.   Service Portfolio

8.1.3.  Strategic Developments

8.1.4.  Financial Overview

8.2.     Cardinal Health

8.2.1.  Business Overview

8.2.2.   Service Portfolio

8.2.3.  Strategic Developments

8.2.4.  Financial Overview

8.3.     3M Healthcare

8.3.1.  Business Overview

8.3.2.   Service Portfolio

8.3.3.  Strategic Developments

8.3.4.  Financial Overview

8.4.     B. Braun Melsungen AG

8.4.1.  Business Overview

8.4.2.   Service Portfolio

8.4.3.  Strategic Developments

8.4.4.  Financial Overview

8.5.     Johnson & Johnson

8.5.1.  Business Overview

8.5.2.   Service Portfolio

8.5.3.  Strategic Developments

8.5.4.  Financial Overview

8.6.     Mölnlycke Health Care AB

8.6.1.  Business Overview

8.6.2.   Service Portfolio

8.6.3.  Strategic Developments

8.6.4.  Financial Overview

8.7.     Ethicon, Inc.

8.7.1.  Business Overview

8.7.2.   Service Portfolio

8.7.3.  Strategic Developments

8.7.4.  Financial Overview

8.8.     Coloplast Group

8.8.1.  Business Overview

8.8.2.   Service Portfolio

8.8.3.  Strategic Developments

8.8.4.  Financial Overview

8.9.     C. R. Bard, Inc.

8.9.1.  Business Overview

8.9.2.   Service Portfolio

8.9.3.  Strategic Developments

8.9.4.  Financial Overview

8.10. Medline Industries, Inc.

8.10.1.      Business Overview

8.10.2.       Service Portfolio

8.10.3.      Strategic Developments

8.10.4.      Financial Overview

9.       Infection Prevention Devices Market Forecast (2017-2027)

9.1.     Global Infection Prevention Devices Revenue (Millions USD) and Growth Rate (2017-2027)

9.2.     Infection Prevention Devices Market Forecast by Regions (2017-2027)

9.2.1.  North America Infection Prevention Devices Market Forecast (2017-2027)

9.2.1.1.  United States Infection Prevention Devices Market Forecast (2017-2027)

9.2.1.2.  Canada Infection Prevention Devices Market Forecast (2017-2027)

9.2.1.3.  Mexico Infection Prevention Devices Market Forecast (2017-2027)

9.2.2.  Europe Infection Prevention Devices Market Forecast (2017-2027)

9.2.2.1.  Germany Infection Prevention Devices Market Forecast (2017-2027)

9.2.2.2.  France Infection Prevention Devices Market Forecast (2017-2027)

9.2.2.3.  UK Infection Prevention Devices Market Forecast (2017-2027)

9.2.2.4.  Russia Infection Prevention Devices Market Forecast (2017-2027)

9.2.2.5.  Italy Infection Prevention Devices Market Forecast (2017-2027)

9.2.2.6.  Rest of Europe Infection Prevention Devices Market Forecast (2017-2027)

9.2.3.  Asia-Pacific Infection Prevention Devices Market Forecast (2017-2027)

9.2.3.1.  China Infection Prevention Devices Market Forecast (2017-2027)

9.2.3.2.  Japan Infection Prevention Devices Market Forecast (2017-2027)

9.2.3.3.  Korea Infection Prevention Devices Market Forecast (2017-2027)

9.2.3.4.  India Infection Prevention Devices Market Forecast (2017-2027)

9.2.3.5.  Southeast Asia Infection Prevention Devices Market Forecast (2017-2027)

9.2.3.6.  Rest of Asia-Pacific Infection Prevention Devices Market Forecast (2017-2027)

9.2.4.  South America Infection Prevention Devices Market Forecast (2017-2027)

9.2.4.1.  Brazil Infection Prevention Devices Market Forecast (2017-2027)

9.2.4.2.  Argentina Infection Prevention Devices Market Forecast (2017-2027)

9.2.4.3.  Columbia Infection Prevention Devices Market Forecast (2017-2027)

9.2.4.4.  Rest of South America Infection Prevention Devices Market Forecast (2017-2027)

9.2.5.  Middle East and Africa Infection Prevention Devices Market Forecast (2017-2027)

9.2.5.1.  Saudi Arabia Infection Prevention Devices Market Forecast (2017-2027)

9.2.5.2.  United Arab Emirates Infection Prevention Devices Market Forecast (2017-2027)

9.2.5.3.  Egypt Infection Prevention Devices Market Forecast (2017-2027)

9.2.5.4.  Nigeria Infection Prevention Devices Market Forecast (2017-2027)

9.2.5.5.  South Africa Infection Prevention Devices Market Forecast (2017-2027)

9.2.5.6.  Turkey Infection Prevention Devices Market Forecast (2017-2027)

9.2.5.7.  Rest of Middle East and Africa Infection Prevention Devices Market Forecast (2017-2027)

9.3.     Infection Prevention Devices Market Forecast by Product (2017-2027)

9.3.1.  Infection Prevention Devices Forecast by Product (2017-2027)

9.3.2.  Infection Prevention Devices Market Share Forecast by Product (2017-2027)

9.4.     Infection Prevention Devices Market Forecast by End User (2017-2027)

9.4.1.  Infection Prevention Devices Forecast by End User (2017-2027)

9.4.2.  Infection Prevention Devices Market Share Forecast by End User (2017-2027)


List of Tables

List of Tables and Figures:

Figure United States Infection Prevention Devices Revenue (Million USD) and Growth Rate (2017-2025)
Figure Canada Infection Prevention Devices Revenue (Million USD) and Growth Rate (2017-2025)
Figure Mexico Infection Prevention Devices Revenue (Million USD) and Growth Rate (2017-2025)
Figure Germany Infection Prevention Devices Revenue (Million USD) and Growth Rate (2017-2025)
Figure France Infection Prevention Devices Revenue (Million USD) and Growth Rate (2017-2025)
Figure UK Infection Prevention Devices Revenue (Million USD) and Growth Rate (2017-2025)
Figure Russia Infection Prevention Devices Revenue (Million USD) and Growth Rate (2017-2025)
Figure Italy Infection Prevention Devices Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Europe Infection Prevention Devices Revenue (Million USD) and Growth Rate (2017-2025)
Figure China Infection Prevention Devices Revenue (Million USD) and Growth Rate (2017-2025)
Figure Japan Infection Prevention Devices Revenue (Million USD) and Growth Rate (2017-2025)
Figure Korea Infection Prevention Devices Revenue (Million USD) and Growth Rate (2017-2025)
Figure India Infection Prevention Devices Revenue (Million USD) and Growth Rate (2017-2025)
Figure Southeast Asia Infection Prevention Devices Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Asia-Pacific Infection Prevention Devices Revenue (Million USD) and Growth Rate (2017-2025)
Figure Brazil Infection Prevention Devices Revenue (Million USD) and Growth Rate (2017-2025)
Figure Argentina Infection Prevention Devices Revenue (Million USD) and Growth Rate (2017-2025)
Figure Columbia Infection Prevention Devices Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of South America Infection Prevention Devices Revenue (Million USD) and Growth Rate (2017-2025)
Figure Saudi Arabia Infection Prevention Devices Revenue (Million USD) and Growth Rate (2017-2025)
Figure United Arab Emirates Infection Prevention Devices Revenue (Million USD) and Growth Rate (2017-2025)
Figure Egypt Infection Prevention Devices Revenue (Million USD) and Growth Rate (2017-2025)
Figure Nigeria Infection Prevention Devices Revenue (Million USD) and Growth Rate (2017-2025)
Figure South Africa Infection Prevention Devices Revenue (Million USD) and Growth Rate (2017-2025)
Figure Turkey Infection Prevention Devices Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Middle East and Africa Infection Prevention Devices Revenue (Million USD) and Growth Rate (2017-2025)
Table Global Infection Prevention Devices Revenue and Revenue Share by Product (2017-2018)
Figure Global Medical Waste Disposable Devices Revenue and Growth Rate (2017-2018)
Figure Global Infection Prevention Supplies Revenue and Growth Rate (2017-2018)
Figure Global Infection Prevention Equipment Revenue and Growth Rate (2017-2018)
Table Global Infection Prevention Devices Revenue and Revenue Share by End User (2017-2018)
Figure Global Lifescience Industries Revenue and Growth Rate (2017-2018)
Figure Global Hospitals Revenue and Growth Rate (2017-2018)
Figure Global Clinical Laboratories Revenue and Growth Rate (2017-2018)
Figure Global Others Revenue and Growth Rate (2017-2018)
Table Global Infection Prevention Devices Revenue by Regions (2017-2018)
Figure North America Infection Prevention Devices Growth Rate (2017-2018)
Figure North America Infection Prevention Devices Revenue and Growth Rate (2017-2018)
Figure North America Infection Prevention Devices by Countries (2017-2018)
Figure North America Infection Prevention Devices Revenue (Million USD) by Countries (2017-2018)
Figure United States Infection Prevention Devices Growth Rate (2017-2018)
Figure United States Infection Prevention Devices Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Canada Infection Prevention Devices Growth Rate (2017-2018)
Figure Canada Infection Prevention Devices Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Mexico Infection Prevention Devices Growth Rate (2017-2018)
Figure Mexico Infection Prevention Devices Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Europe Infection Prevention Devices Growth Rate (2017-2018)
Figure Europe Infection Prevention Devices Revenue and Growth Rate (2017-2018)
Figure Europe Infection Prevention Devices by Countries (2017-2018)
Figure Europe Infection Prevention Devices Revenue (Million USD) by Countries (2017-2018)
Figure Germany Infection Prevention Devices Growth Rate (2017-2018)
Figure Germany Infection Prevention Devices Revenue (Millions USD) and Growth Rate (2017-2018)
Figure France Infection Prevention Devices Growth Rate (2017-2018)
Figure France Infection Prevention Devices Revenue (Millions USD) and Growth Rate (2017-2018)
Figure UK Infection Prevention Devices Growth Rate (2017-2018)
Figure UK Infection Prevention Devices Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Russia Infection Prevention Devices Growth Rate (2017-2018)
Figure Russia Infection Prevention Devices Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Italy Infection Prevention Devices Growth Rate (2017-2018)
Figure Italy Infection Prevention Devices Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Europe Infection Prevention Devices Growth Rate (2017-2018)
Figure Rest of Europe Infection Prevention Devices Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Asia-Pacific Infection Prevention Devices Growth Rate (2017-2018)
Figure Asia-Pacific Infection Prevention Devices Revenue and Growth Rate (2017-2018)
Figure Asia-Pacific Infection Prevention Devices by Countries (2017-2018)
Figure Asia-Pacific Infection Prevention Devices Revenue (Million USD) by Countries (2017-2018)
Figure China Infection Prevention Devices Growth Rate (2017-2018)
Figure China Infection Prevention Devices Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Japan Infection Prevention Devices Growth Rate (2017-2018)
Figure Japan Infection Prevention Devices Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Korea Infection Prevention Devices Growth Rate (2017-2018)
Figure Korea Infection Prevention Devices Revenue (Millions USD) and Growth Rate (2017-2018)
Figure India Infection Prevention Devices Growth Rate (2017-2018)
Figure India Infection Prevention Devices Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Southeast Asia Infection Prevention Devices Growth Rate (2017-2018)
Figure Southeast Asia Infection Prevention Devices Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Infection Prevention Devices Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Infection Prevention Devices Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South America Infection Prevention Devices Growth Rate (2017-2018)
Figure South America Infection Prevention Devices Revenue and Growth Rate (2017-2018)
Figure South America Infection Prevention Devices by Countries (2017-2018)
Figure South America Infection Prevention Devices Revenue (Million USD) by Countries (2017-2018)
Figure Brazil Infection Prevention Devices Growth Rate (2017-2018)
Figure Brazil Infection Prevention Devices Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Argentina Infection Prevention Devices Growth Rate (2017-2018)
Figure Argentina Infection Prevention Devices Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Columbia Infection Prevention Devices Growth Rate (2017-2018)
Figure Columbia Infection Prevention Devices Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of South America Infection Prevention Devices Growth Rate (2017-2018)
Figure Rest of South America Infection Prevention Devices Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Middle East and Africa Infection Prevention Devices Growth Rate (2017-2018)
Figure Middle East and Africa Infection Prevention Devices Revenue and Growth Rate (2017-2018)
Figure Middle East and Africa Infection Prevention Devices by Countries (2017-2018)
Figure Middle East and Africa Infection Prevention Devices Revenue (Million USD) by Countries (2017-2018)
Figure Saudi Arabia Infection Prevention Devices Growth Rate (2017-2018)
Figure Saudi Arabia Infection Prevention Devices Revenue (Millions USD) and Growth Rate (2017-2018)
Figure United Arab Emirates Infection Prevention Devices Growth Rate (2017-2018)
Figure United Arab Emirates Infection Prevention Devices Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Egypt Infection Prevention Devices Growth Rate (2017-2018)
Figure Egypt Infection Prevention Devices Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Nigeria Infection Prevention Devices Growth Rate (2017-2018)
Figure Nigeria Infection Prevention Devices Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South Africa Infection Prevention Devices Growth Rate (2017-2018)
Figure South Africa Infection Prevention Devices Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Turkey Infection Prevention Devices Growth Rate (2017-2018)
Figure Turkey Infection Prevention Devices Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Infection Prevention Devices Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Infection Prevention Devices Revenue (Millions USD) and Growth Rate (2017-2018)
Table PAUL HARTMANN AG Infection Prevention Devices Financial Overview
Table Cardinal Health Infection Prevention Devices Financial Overview
Table 3M Healthcare Infection Prevention Devices Financial Overview
Table B. Braun Melsungen AG Infection Prevention Devices Financial Overview
Table Johnson & Johnson Infection Prevention Devices Financial Overview
Table Mölnlycke Health Care AB Infection Prevention Devices Financial Overview
Table Ethicon, Inc. Infection Prevention Devices Financial Overview
Table Coloplast Group Infection Prevention Devices Financial Overview
Table C. R. Bard, Inc. Infection Prevention Devices Financial Overview
Table Medline Industries, Inc. Infection Prevention Devices Financial Overview
Figure Global Infection Prevention Devices Revenue (Millions USD) and Growth Rate (2018-2025)
Table Infection Prevention Devices Market Forecast by Regions (2018-2025)
Figure North America Infection Prevention Devices Market Forecast (2018-2025)
Figure United States Infection Prevention Devices Market Forecast (2018-2025)
Figure Canada Infection Prevention Devices Market Forecast (2018-2025)
Figure Mexico Infection Prevention Devices Market Forecast (2018-2025)
Figure Europe Infection Prevention Devices Market Forecast (2018-2025)
Figure Germany Infection Prevention Devices Market Forecast (2018-2025)
Figure France Infection Prevention Devices Market Forecast (2018-2025)
Figure UK Infection Prevention Devices Market Forecast (2018-2025)
Figure Russia Infection Prevention Devices Market Forecast (2018-2025)
Figure Italy Infection Prevention Devices Market Forecast (2018-2025)
Figure Rest of Europe Infection Prevention Devices Market Forecast (2018-2025)
Figure Asia-Pacific Infection Prevention Devices Market Forecast (2018-2025)
Figure China Infection Prevention Devices Market Forecast (2018-2025)
Figure Japan Infection Prevention Devices Market Forecast (2018-2025)
Figure Korea Infection Prevention Devices Market Forecast (2018-2025)
Figure India Infection Prevention Devices Market Forecast (2018-2025)
Figure Southeast Asia Infection Prevention Devices Market Forecast (2018-2025)
Figure Rest of Asia-Pacific Infection Prevention Devices Market Forecast (2018-2025)
Figure South America Infection Prevention Devices Market Forecast (2018-2025)
Figure Brazil Infection Prevention Devices Market Forecast (2018-2025)
Figure Argentina Infection Prevention Devices Market Forecast (2018-2025)
Figure Columbia Infection Prevention Devices Market Forecast (2018-2025)
Figure Rest of South America Infection Prevention Devices Market Forecast (2018-2025)
Figure Middle East and Africa Infection Prevention Devices Market Forecast (2018-2025)
Figure Saudi Arabia Infection Prevention Devices Market Forecast (2018-2025)
Figure United Arab Emirates Infection Prevention Devices Market Forecast (2018-2025)
Figure Egypt Infection Prevention Devices Market Forecast (2018-2025)
Figure Nigeria Infection Prevention Devices Market Forecast (2018-2025)
Figure South Africa Infection Prevention Devices Market Forecast (2018-2025)
Figure Turkey Infection Prevention Devices Market Forecast (2018-2025)
Figure Rest of Middle East and Africa Infection Prevention Devices Market Forecast (2018-2025)
Figure Global Infection Prevention Devices Forecast by Product (2018-2025)
Figure Global Infection Prevention Devices Market Share Forecast by Product (2018-2025)
Figure Global Infection Prevention Devices Forecast by Product (2018-2025)
Figure Global Infection Prevention Devices Forecast by End User (2018-2025)
Figure Global Infection Prevention Devices Market Share Forecast by End User (2018-2025)
Figure Global Infection Prevention Devices Forecast by End User (2018-2025)

Please Note: Data related to the Companies are subject to Availability.


Research Methodology

We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.

Data Mining

Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.

Data Collection Matrix

Data Collection Matrix

Supply Side

Demand Side

Primary Data Sources

  • Manufacturers
  • Distributors & Wholesalers
  • GPOs
  • Physicians/Specialist
  • Healthcare Providers
  • Consumers

Secondary Data Sources

  • Annual Reports/SEC Filings/ Investor Presentations/ Press Releases
  • Government/Associations Publications
  • Case Studies
  • Reference Customers

 

Market Modeling and Forecasting

We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.

  • Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
  • Number of patients for particular device or medical procedure and
  • Repeated use of particular device depending on health and condition of patient
  • Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.

We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.

Data Validation

We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.

Data Triangulation

data triangulation

Industry Analysis

Qualitative Data

Quantitative Data (2017-2025)

  • Market Dynamics (Drivers, Restraints, and Challenges)
  • Industry Trend Analysis
  • Market Opportunities
  • Government Policies and Regulations, Patent Analysis, and Reimbursement Policies
  • Porter’s Five Forces and PESTLE Analysis
  • Key Developments and Competitive Landscape
  • Market Assessment and Forecast
  • Market Assessment and Forecast, By Product
  • Market Assessment and Forecast, By Technology
  • Market Assessment and Forecast, By Application
  • Market Assessment and Forecast, By End User
  • Market Assessment and Forecast, By Region/Country

License Type

For Any Assistance

*
*
*
*
*